Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014

Silvia S Martins, Luis E Segura, Julian Santaella-Tenorio, Alexander Perlmutter, Miriam C Fenton, Magdalena Cerdá, Katherine M Keyes, Lilian A Ghandour, Carla L Storr, Deborah S Hasin, Silvia S Martins, Luis E Segura, Julian Santaella-Tenorio, Alexander Perlmutter, Miriam C Fenton, Magdalena Cerdá, Katherine M Keyes, Lilian A Ghandour, Carla L Storr, Deborah S Hasin

No abstract available

Keywords: Heroin; Nonmedical prescription opioid use; Prescription opioid disorder; Trend analysis; Youth drug use.

Conflict of interest statement

Dr. Hasin is Principal Investigator of a study on a measure of addiction to prescription opioids funded by InVentive Health Consulting, which combines support from nine pharmaceutical companies. All other authors have no conflict of interest to declare.

Figures

Figure 1

Adjusted prevalence of prescription opioid use disorder among past-year nonmedically prescription opioids users, stratified by age, in the U.S. household population *Yearly adjusted prevalence compared to 2002, p < 0.05. Model adjusted for sex & ethnicity.

Figure 2

Average change in the prevalence of prescription opioid use disorder, from 2002–2014, among NMPO users by age groups. Y axis value of 0 represents the mean prevalence of prescription opioid use disorder in 2002 among NMPO users, which was 8.81% for adolescents, 9.37% for emerging adults, and 12.95% for young adults.

Figure 3

Adjusted prevalence of heroin use among NMPO users in the U.S. household population (2002–14). *Yearly adjusted prevalence compared to 2002, p < 0.05. Model adjusted for sex & ethnicity.

Figure 4

Total percentage change from 2002 to 2014 in heroin use prevalence among NMPO users, in the U.S. household population, by age groups. Y axis value of 0 represents the mean prevalence of heroin use in 2002 among NMPO users, which was 1.6% for adolescents, 2.89 for emerging adults, and 3.56 for young adults.